Unknown

Dataset Information

0

Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.


ABSTRACT: Cullin-3 (CUL3) mutations (CUL3?9) were previously identified in hypertensive patients with pseudohypoaldosteronism type-II (PHAII), but the mechanism causing hypertension and whether this is driven by renal tubular or extratubular mechanisms remains unknown. We report that selective expression of CUL3?9 in smooth muscle acts by interfering with expression and function of endogenous CUL3, resulting in impaired turnover of the CUL3 substrate RhoA, increased RhoA activity, and augmented RhoA/Rho kinase signaling. This caused vascular dysfunction and increased arterial pressure under baseline conditions and a marked increase in arterial pressure, collagen deposition, and vascular stiffness in response to a subpressor dose of angiotensin II, which did not cause hypertension in control mice. Inhibition of total cullin activity increased the level of CUL3 substrates cyclin E and RhoA, and expression of CUL3?9 decreased the level of the active form of endogenous CUL3 in human aortic smooth muscle cells. These data indicate that selective expression of the Cul3?9 mutation in vascular smooth muscle phenocopies the hypertension observed in Cul3?9 human subjects and suggest that mutations in CUL3 cause human hypertension in part through a mechanism involving smooth muscle dysfunction initiated by a loss of CUL3-mediated degradation of RhoA.

SUBMITTER: Agbor LN 

PROVIDER: S-EPMC5111503 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.

Agbor Larry N LN   Ibeawuchi Stella-Rita C SC   Hu Chunyan C   Wu Jing J   Davis Deborah R DR   Keen Henry L HL   Quelle Frederick W FW   Sigmund Curt D CD  

JCI insight 20161117 19


Cullin-3 (<i>CUL3</i>) mutations (<i>CUL3</i>Δ<i>9</i>) were previously identified in hypertensive patients with pseudohypoaldosteronism type-II (PHAII), but the mechanism causing hypertension and whether this is driven by renal tubular or extratubular mechanisms remains unknown. We report that selective expression of CUL3Δ9 in smooth muscle acts by interfering with expression and function of endogenous CUL3, resulting in impaired turnover of the CUL3 substrate RhoA, increased RhoA activity, and  ...[more]

Similar Datasets

| S-EPMC6675584 | biostudies-literature
| S-EPMC6727156 | biostudies-literature
| S-EPMC3474846 | biostudies-literature
| S-EPMC2936100 | biostudies-literature
| S-EPMC8039951 | biostudies-literature
| S-EPMC2275166 | biostudies-literature
| S-EPMC5340142 | biostudies-literature
| S-EPMC8748448 | biostudies-literature
| S-EPMC2749749 | biostudies-literature
| S-EPMC4982825 | biostudies-literature